Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2
ConditionMale Breast Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age66+
SponsorInstitut Claudius Regaud
About this trial
This is an interventional, prospective, single-center study designed to collect and describe genetic, environmental and psychosocial control data from male participants. The participants did not have any prior history of cancer at the time of the oncogenetic consultation and do not have the family mutation researched during the oncogenetic consultation (targeted genetic testing). The participants are referenced in the IUCT-O medical records as family members of patients suffering from male breast cancer.
The study will be conducted on a population of 120 participants.
Eligibility criteria
Qualifiers
1. A male volunteer participant with no personal history of cancer, registered in the IUCT-O oncogenetics database as a relative of a patient carrying a pathogenic or likely pathogenic variant in one of the cancer predisposition genes routinely analyzed at the oncogenetics laboratory
2. Age ≥ 66 years
3. Participant with no known family relationship to a patient of the MATADOR1 cohort
4. Participant who has undergone an oncogenetic consultation at the IUCT-O
Disqualifiers
1. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).
Trial design
Treatments tested in this trial
- Questionnaire completion
- Genetic analysis (WES)
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Institut Claudius Regaud
Lead sponsor
Ligue contre le cancer, France
Collaborator
Source ClinicalTrials.gov